DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/b75s9c/acute_heart) has announced the addition of the "Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015" report to their offering.
'Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015' Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Acute Heart Failure.
- A snapshot of the global Market therapeutics scenario for Acute Heart Failure.
- A review of the marketed products under prescription for Acute Heart Failure, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Acute Heart Failure with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Acute Heart Failure drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Acute Heart Failure drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Acute Heart Failure drugs.
- Coverage of Acute Heart Failure Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure from 2012-2016.
For more information visit http://www.researchandmarkets.com/research/b75s9c/acute_heart